SoCalBio Networking Forum

October 29, 2009
4:00 - 7:00 pm
Luxe Hotel

11461 Sunset Boulevard
Los Angeles, CA 90049

Admission: Non-Member= $75     SoCalBio Member= $40   Academic/Gov./Nonprofit= $40

RSVP Now: https://www.123signup.com/register?id=jmfvc

Program

Why Bioscience Companies Should Care About Social Media

Online media -- Twitter, Facebook, LinkedIn, and many others -- are becoming more and more prevalent every day. With new information being discussed in blogs, social communities, news feeds and even online video conversation. Keeping up with online conversations can be a daunting task. But, interesting conversations are happening all over the web, making the resources worth the effort. And, now, it is becoming clear within the life science community -- whether you sell stents, heart monitoring software, medical tubing, the famous blue pill or products only in development -- you will need to actively listen to what is being discussed online because your customers, decision makers, influencers and investors are participating online, and discussing your products and service on blogs, videos, podcasts, and news articles .... Join us to participate in a lively discussion regarding the potential role of social media in shaping biocommerce. 

Moderator

  • Susan Tellem, Partner, Tellem Worldwide, Inc.

Keynote Presenter

  • Sasha Strauss, Managing Director, Innovation Protocol

Discussion Panel Participants

  • Mark Davidson, Consultant

  • Meredith Dow, Senior Partner, Life Sciences Practice, Proven Inc.

  • William Gunn, Senior Assay Development, Genalyte

  • Robert Hess, Sr Fellow, Center for the Digital Future

  • Dr. Jonathan Usuka, Biotech Executive, Celgene


Agenda:

4:00 pm      Registration & Cocktail Reception
5:15 pm      Introductions
5:30 pm      Presentations & Discussion
7:00 pm      Forum Adjourns

Sponsors

Wells Fargo

Organized by the Southern California Biomedical Council, the SoCalBio Networking Forum is a monthly business mixer that brings together leaders from all segments of the life-science industry to share insights and learn about:

  • Innovation best practices
  • Device and biotech business trends
  • Technology convergence opportunities, and
  • Broad-reaching public policies shaping the commercialization of innovations and healthcare service delivery in the U.S. and abroad.

For more information, contact Ahmed Enany, President & CEO, Southern California Biomedical Council at 213-236-4890 or send e-mail to scbc@socalbio.org.